Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Mercado Libre
MELI
$98.9B
| $7.14M | ﹤0.01% |
38,600
| – | – |
|
1827
PUT
Motorola Solutions
MSI
$80.6B
| $7.13M | ﹤0.01% |
93,500
+54,800
| +142% | +$4M |
|
1828
CALL
Cleveland-Cliffs
CLF
$6.58B
| $7.12M | ﹤0.01% |
1,217,800
-938,400
| -44% | -$6.12M |
|
1829
Invesco DB Precious Metals Fund
DBP
$275M
| $7.11M | ﹤0.01% |
+175,079
| New | +$7.24M |
|
1830
CALL
United Therapeutics
UTHR
$22.2B
| $7.08M | ﹤0.01% |
60,000
-27,300
| -31% | -$3.28M |
|
|
LLTC
1831
PUT
DELISTED
Linear Technology Corp
LLTC
| $7.06M | ﹤0.01% |
119,100
+52,700
| +79% | +$2.96M |
|
|
ARIA
1832
PUT
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $7.06M | ﹤0.01% |
515,700
+296,300
| +135% | +$2.98M |
|
1833
PUT
Five Below
FIVE
$14.2B
| $7.06M | ﹤0.01% |
175,200
+3,400
| +2% | +$157K |
|
1834
CALL
KeyCorp
KEY
$23.6B
| $7.05M | ﹤0.01% |
579,600
+157,800
| +37% | +$1.89M |
|
|
CY
1835
CALL
DELISTED
Cypress Semiconductor
CY
| $7.05M | ﹤0.01% |
579,400
+64,300
| +12% | +$735K |
|
1836
PUT
ANI Pharmaceuticals
ANIP
$1.71B
| $7.04M | ﹤0.01% |
106,100
-1,400
| -1% | -$87.6K |
|
|
SAFM
1837
PUT
DELISTED
Sanderson Farms Inc
SAFM
| $7.03M | ﹤0.01% |
73,000
-99,600
| -58% | -$9.12M |
|
1838
CALL
Weibo
WB
$1.73B
| $7.03M | ﹤0.01% |
140,200
-16,100
| -10% | -$666K |
|
|
FRGI
1839
PUT
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $7.03M | ﹤0.01% |
292,900
+234,700
| +403% | +$5.68M |
|
1840
CALL
Popular Inc
BPOP
$10.8B
| $7.03M | ﹤0.01% |
183,800
-75,000
| -29% | -$2.67M |
|
1841
AT&T
T
$177B
| $7.02M | ﹤0.01% |
228,787
-247,796
| -52% | -$7.83M |
|
1842
CALL
TechnipFMC
FTI
$29.7B
| $7.01M | ﹤0.01% |
317,453
-228,480
| -42% | -$4.62M |
|
1843
iShares US Medical Devices ETF
IHI
$3.42B
| $7.01M | ﹤0.01% |
+289,212
| New | +$6.88M |
|
|
LTRPA
1844
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $7M | ﹤0.01% |
320,464
-148,055
| -32% | -$3.24M |
|
|
DCP
1845
CALL
DELISTED
DCP Midstream, LP
DCP
| $6.99M | ﹤0.01% |
197,700
+138,200
| +232% | +$4.71M |
|
|
ALR
1846
PUT
DELISTED
Alere Inc
ALR
| $6.98M | ﹤0.01% |
161,500
-158,500
| -50% | -$6.46M |
|
1847
CALL
Lamar Advertising Co
LAMR
$15.4B
| $6.97M | ﹤0.01% |
106,700
+24,400
| +30% | +$1.58M |
|
|
MRSH
1848
CALL
Marsh
MRSH
$92.2B
| $6.97M | ﹤0.01% |
103,600
-9,800
| -9% | -$656K |
|
|
EGN
1849
CALL
DELISTED
Energen
EGN
| $6.97M | ﹤0.01% |
120,700
+39,400
| +48% | +$2.06M |
|
1850
CALL
Enbridge
ENB
$110B
| $6.97M | ﹤0.01% |
157,500
+117,800
| +297% | +$4.94M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.99B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,278 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.